INTU vs MRK: Which Is the Better Buy?
Side-by-side comparison of Intuit Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
Intuit Inc. · Technology
$396.57
+45.0% upside to fair value
High Conviction
Grade A-
VS
Merck & Co., Inc. · Healthcare
$114.27
+3.3% upside to fair value
Grade C
High Quality
QuantHub Verdict
INTU has more upside to fair value
(+45.0%).
INTU trades at a lower forward P/E
(19.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
INTU |
MRK |
| Current Price |
$396.57 |
$114.27 |
| Fair Value Estimate |
$575.03 |
$118.00 |
| Upside to Fair Value |
+45.0%
|
+3.3%
|
| Market Cap |
$110.4B |
$282.2B |
| Forward P/E |
19.5x
|
22.4x
|
| EV / EBITDA |
19.0x
|
13.5x
|
| Price / Sales |
5.9x
|
4.3x
|
| Price / FCF |
18.1x
|
20.2x
|
| Revenue Growth YoY |
+15.6%
|
+5.0%
|
| Gross Margin |
80.8%
|
81.9%
|
| Operating Margin |
26.1%
|
27.5%
|
| Return on Equity |
19.6%
|
5.6%
|
| Dividend Yield |
1.17% |
2.91% |
| FCF Yield |
5.51%
|
4.95%
|
| Analyst Consensus |
Buy
|
Overweight
|
Investment Thesis
Intuit is a near-monopoly financial operating system for 60+ million American households and small businesses. TurboTax handles 40%+ of US e-filed returns; QuickBooks is so deeply embedded in SMB workflows it has become the default accounting standard. The stock has fallen 51% from its 2025 high as markets price in AI disruption that has not materialized at scale and may not, since tax complexity…
Merck delivered a clean Q1 2026 operational beat on April 30, with revenue of 16.3 billion dollars growing 5 percent year over year and Keytruda sales rising 12 percent to 8.0 billion dollars. The reported loss of 1.28 dollars per share, though better than the negative 1.47 dollar consensus estimate, reflected a 3.62 dollar per share IPR and D charge tied to the Cidara Therapeutics acquisition an…
Accumulation Zones
| Metric |
INTU |
MRK |
| Zone Low |
$431.27 |
$88.50 |
| Zone High |
$488.78 |
$100.30 |
| In Buy Zone? |
Yes
|
No
|